Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Pharmacotherapy|August 14, 2002
Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipientsPaul O Gubbins, Scott R Penzak, Sabrena Polston, et al.Pharmacotherapy|July 26, 2006
Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probeSarah M Robertson, Elizabeth Formentini, Raul M Alfaro, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Antiretroviral drug content in products from developing countriesScott R Penzak, Edward P Acosta, Michele Turner, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individualsKristin H Busse, Elizabeth Formentini, Raul M Alfaro, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2005
Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteersScott R Penzak, Elizabeth Formentini, Raul M Alfaro, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
A potentially significant interaction between efavirenz and phenytoin: a case report and review of the literatureSarah M Robertson, Scott R Penzak, Jason Lane, et al.Pharmacotherapy|March 7, 2012
Impaired maraviroc and raltegravir clearance in a human immunodeficiency virus-infected patient with end-stage liver disease and renal impairment: a management dilemmaAlice K Pau, Scott R Penzak, Sarita D Boyd, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosisMonique E Cho, David C Smith, Mary H Branton, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjectsSarah M Robertson, Frank Maldarelli, Ven Natarajan, et al.British Journal of Clinical Pharmacology|March 18, 2006
Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohortSarah M Robertson, Elizabeth Formentini, Raul M Alfaro, et al.Pageof 8